Hatem Abou-Sayed
Founder at ELEVAI LABS INC.
Net worth: 905 457 $ as of 30/05/2024
Profile
Hatem Abou-Sayed is the founder of Elevai Labs, Inc. founded in 2020, where he holds the title of Director & Chief Medical Officer.
He is currently a Director at Fruit Street Health, P.B.C.
and a Managing Member at Zamzam Skin, LLC since 2017.
Dr. Abou-Sayed was a Vice-President at Interpreta, Inc. from 2015 to 2017.
He holds an MBA from Northwestern University, an undergraduate degree from the University of California, Berkeley, and a doctorate from the University of California Irvine School of Medicine.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
ELEVAI LABS INC.
7.26% | 24/03/2024 | 1,371,905 ( 7.26% ) | 905 457 $ | 30/05/2024 |
Hatem Abou-Sayed active positions
| Companies | Position | Start |
|---|---|---|
| ELEVAI LABS INC. | Founder | 31/12/2019 |
Fruit Street Health, P.B.C.
 Fruit Street Health, P.B.C. Internet Software/ServicesTechnology Services Fruit Street Health, Inc. develops software applications for the healthcare professionals. It offers digital health and telemedicine to deliver the Center for Disease Control & Prevention’s (CDC’s) National Diabetes Prevention Program (DPP). It helps to prevent and treat lifestyle related disease using telemedicine, connected devices and mobile applications. The company was founded by Laurence Girard in 2014 and is headquartered in New York, NY. | Director/Board Member | - |
Former positions of Hatem Abou-Sayed
| Companies | Position | End |
|---|---|---|
Interpreta, Inc.
 Interpreta, Inc. Internet Software/ServicesTechnology Services Part of Centene Corp., Interpreta, Inc. is a healthcare analytics company that continuously updates, interprets, and synchronizes clinical data to create personalized roadmaps for timely care. The company is based in San Diego, CA. The company's real-time insights provide guidance to physicians, care managers, and health plans for quality improvement, clinical prioritization, population management, and precision medicine. The company was founded by Ahmed F. Ghouri, who has been the CEO since incorporation. Interpreta was acquired by Centene Corp. on March 27, 2018 for $175.92 million. | Corporate Officer/Principal | 31/12/2016 |
Training of Hatem Abou-Sayed
| University of California, Berkeley | Undergraduate Degree |
| University of California Irvine School of Medicine | Doctorate Degree |
| Northwestern University | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Fruit Street Health, P.B.C.
Fruit Street Health, P.B.C. Internet Software/ServicesTechnology Services Fruit Street Health, Inc. develops software applications for the healthcare professionals. It offers digital health and telemedicine to deliver the Center for Disease Control & Prevention’s (CDC’s) National Diabetes Prevention Program (DPP). It helps to prevent and treat lifestyle related disease using telemedicine, connected devices and mobile applications. The company was founded by Laurence Girard in 2014 and is headquartered in New York, NY. | Technology Services |
| Elevai Labs, Inc. | |
Interpreta, Inc.
Interpreta, Inc. Internet Software/ServicesTechnology Services Part of Centene Corp., Interpreta, Inc. is a healthcare analytics company that continuously updates, interprets, and synchronizes clinical data to create personalized roadmaps for timely care. The company is based in San Diego, CA. The company's real-time insights provide guidance to physicians, care managers, and health plans for quality improvement, clinical prioritization, population management, and precision medicine. The company was founded by Ahmed F. Ghouri, who has been the CEO since incorporation. Interpreta was acquired by Centene Corp. on March 27, 2018 for $175.92 million. | Technology Services |
- Stock Market
- Insiders
- Hatem Abou-Sayed
